Neurones S.A. (EPA:NRO)
48.95
+0.35 (0.72%)
Apr 1, 2025, 12:45 PM CET
Neurones Statistics
Total Valuation
Neurones has a market cap or net worth of EUR 1.18 billion. The enterprise value is 1.01 billion.
Market Cap | 1.18B |
Enterprise Value | 1.01B |
Important Dates
The last earnings date was Wednesday, March 5, 2025.
Earnings Date | Mar 5, 2025 |
Ex-Dividend Date | Jun 12, 2024 |
Share Statistics
Neurones has 24.27 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 24.27M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 63.75% |
Owned by Institutions (%) | 13.53% |
Float | 8.80M |
Valuation Ratios
The trailing PE ratio is 22.47.
PE Ratio | 22.47 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 19.19 |
EV / Sales | 1.24 |
EV / EBITDA | 11.73 |
EV / EBIT | 12.93 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 118,324 |
Profits Per Employee | 7,665 |
Employee Count | 7,087 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.11% in the last 52 weeks. The beta is 0.58, so Neurones's price volatility has been lower than the market average.
Beta (5Y) | 0.58 |
52-Week Price Change | +6.11% |
50-Day Moving Average | 47.45 |
200-Day Moving Average | 44.72 |
Relative Strength Index (RSI) | 50.80 |
Average Volume (20 Days) | 5,222 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Neurones had revenue of EUR 810.40 million and earned 52.50 million in profits.
Revenue | 810.40M |
Gross Profit | 810.40M |
Operating Income | 77.90M |
Pretax Income | 88.10M |
Net Income | 52.50M |
EBITDA | 85.92M |
EBIT | 77.90M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | n/a |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 9.61% and 6.48%.
Gross Margin | 100.00% |
Operating Margin | 9.61% |
Pretax Margin | 10.87% |
Profit Margin | 6.48% |
EBITDA Margin | 10.60% |
EBIT Margin | 9.61% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.30, which amounts to a dividend yield of 2.67%.
Dividend Per Share | 1.30 |
Dividend Yield | 2.67% |
Dividend Growth (YoY) | 9.09% |
Years of Dividend Growth | 2 |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | 2.67% |
Earnings Yield | 4.45% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |